Overview Soliris 300 mg Injection is a groundbreaking monoclonal antibody therapy used for managing rare but serious medical conditions caused by uncontrolled activation of the complement system. Containing Eculizumab, Soliris is the first-in-class terminal complement inhibitor approved for several life-threatening diseases. Approved by the FDA, EMA, and regulatory authorities globally, Soliris has transformed the treatment […]
